Liver cirrhosis is one of the major consequences of hepatitis B virus ( HBV ) infection , and transplantation of autologous bone marrow mesenchymal stem cells ( ABMSCs ) is one of promising therapies for patients with HBV-related liver cirrhosis ( HBV-LC ) .